Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

33.72
+1.454.48%
Pre-market: 33.51-0.2100-0.62%07:07 EDT
Volume:2.41M
Turnover:81.75M
Market Cap:2.42B
PE:-5.72
High:35.09
Open:32.25
Low:32.02
Close:32.28
52wk High:56.05
52wk Low:21.15
Shares:71.71M
Float Shares:62.80M
Volume Ratio:1.53
T/O Rate:3.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8984
EPS(LYR):-4.6644
ROE:-91.75%
ROA:-46.76%
PB:5.93
PE(LYR):-7.23

Loading ...

3 Best Stocks With 100%+ Upside to Buy This Week, According to Analysts

TIPRANKS
·
13 hours ago

Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
Aug 18

Vera Therapeutics Price Target Maintained with a $34.00/Share by Wedbush

Dow Jones
·
Aug 17

Vera Rises on Early Kidney Function Data in FDA Review

Reuters
·
Aug 15

Analyst Maintains Buy on Vera Therapeutics, Cutting Trutakna Price Target to $90 Amid Rising IgAN Competition

TIPRANKS
·
Aug 12

Analyst Sees Vera Well Positioned for Trutakna IgAN Launch, Sustained Uptake and Long‑Term Value Creation

TIPRANKS
·
Aug 12

Jefferies Sticks to Its Buy Rating for Vera Therapeutics (VERA)

TIPRANKS
·
Aug 11

Vera Therapeutics Price Target Cut to $34.00/Share from $43.00 by Wedbush

Dow Jones
·
Aug 11

Vera Therapeutics, Inc. : Wedbush Cuts Target Price to $34 from $43

THOMSON REUTERS
·
Aug 11

Wedbush Adjusts Price Target on Vera Therapeutics to $34 From $43, Maintains Neutral Rating

MT Newswires Live
·
Aug 11

Vera Therapeutics (VERA) Gets a Buy from Bank of America Securities

TIPRANKS
·
Aug 11

Vera Therapeutics Q2 Loss Widens Less than Expected

Reuters
·
Aug 11

Vera Therapeutics Q2 EPS $(1.52) Beats $(1.61) Estimate

Benzinga Earnings
·
Aug 11

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Vera Therapeutics Q2 FY26 Net Loss Widens to $109.5 Million; Loss Per Share Rises to $1.52

Reuters
·
Aug 11

Vera Therapeutics, - Anticipates Sbla Submission to FDA for Trutakna in Q4 2026

THOMSON REUTERS
·
Aug 11

Vera Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

GlobeNewswire
·
Aug 11

Vera Therapeutics Grants Inducement Equity Awards to New Chief Regulatory Officer, Hires

Reuters
·
Aug 08

Vera Therapeutics Names Nancy Lee Boman as Chief Regulatory Officer in Initial Beneficial Ownership Filing

Reuters
·
Aug 06

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Vera Therapeutics (VERA)

TIPRANKS
·
Aug 05